Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function

Transplantation Proceedings

Volumn 37, Issue 9, 2005, Pages 3736-3737

  Gonzalez E ^a   Gutierrez E ^a   Hernandez Y ^a   Rosello G ^a   Gutierrez M J ^a   Gutierrez Martinez E ^a   Manzanera, M J ^a   Garcia J A ^a   Praga, M ^a   Morales, J M ^a   Andres A ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; CADAVER DONOR; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; FEMALE; FOLLOW UP; GRAFT DYSFUNCTION; GRAFT FAILURE; GRAFT REJECTION; HIGH RISK PATIENT; HUMAN; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MALE; NEPHROTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 29544451715     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.09.176     Document Type: Conference Paper

References (5)

1. J. Hakimi, D. Mould, T.A. Waldmann W.J. Harris J.R. Adair Antibody Therapeutics 1997 CRC Press New York 227
2. F. Vicenti, R. Kirkman, S. Light Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation N Engl J Med 338 1998 161
3. B.D. Kahan, P.R. Rajagopalan, M. Hall Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody Transplantation 67 1999 276
4. B. Nashan, S. Light, I.R. Hardie Reduction of acute renal allograft rejection by daclizumab Transplantation 67 1999 110
5. L.J. Swinnen, M.R. Costanzo-Nordin, S.G. Fisher Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients N Engl J Med 323 1990 1723